Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study

Background and Objectives Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal on addictions 2020-11, Vol.29 (6), p.485-491
Hauptverfasser: Iheanacho, Theddeus, Payne, Kevin, Tsai, Jack
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 491
container_issue 6
container_start_page 485
container_title The American journal on addictions
container_volume 29
creator Iheanacho, Theddeus
Payne, Kevin
Tsai, Jack
description Background and Objectives Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population. This study describes a pilot Mobile Community‐based Access Team (M‐CAT) that used mobile technology and FaceTime in addition to existing community‐based case management programs to provide BUP treatment for veterans with OUD experiencing homelessness who had difficulties engaging in the regular BUP clinic. Methods We conducted a retrospective chart review of veterans enrolled in M‐CAT or the usual BUP clinic between January 2015 and December 2017 (N = 36). We ed demographic, medical, substance use, prescription, health care utilization, and drug use data from medical records. Results Twelve veterans were enrolled in M‐CAT and 24 were enrolled in BUP clinic. Mean retention in treatment was 19.2 months (standard deviation [SD] = 10.2) in M‐CAT and 36 months (SD = 27.6) in BUP clinic. At the endpoint, 66.7% (n = 8) in M‐CAT and 100% (n = 24) in BUP clinic remained on BUP. Discussion and Conclusion M‐CAT is an innovative and tailored pilot project that successfully integrated specific OUD medication treatment into existing case management programs for veterans experiencing homelessness using mobile technology and Facetime. M‐CAT can potentially increase utilization of BUP for OUD among high‐risk population of veterans experiencing homelessness who are otherwise not engaged in treatment. Scientific Significance Integrating telemedicine, BUP treatment, and community‐based case management to treat OUD among veterans experiencing homelessness is feasible with high treatment retention. (Am J Addict 2020;29:485–491)
doi_str_mv 10.1111/ajad.13055
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32367557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJAD13055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3295-29a4e6279ac4604fb0003e9aef84f0e82275d55b0a2ea861a84ad4de8a9974143</originalsourceid><addsrcrecordid>eNqNkd9O1TAYwBsjEQRvfADTa2HYbu22encYIBoMJIJeLt_Wb1Jy1i5tFzl3vICJz-iT0ONBLo1f0rRpft-f_krIa84OeYp3cAv6kBdMymdkh8ucZ6xQ_Hk6p6uMCVVuk5ch3LIUtSpfkO0iL8pKymqH_PzsOrPEA9q4cZytiavf97-OIKCmR_Pk0To_3RiL9MojxBFtpIPz9CtG9GADPbmb0Bu0vbHf6ZkbcYkh2LToNxNv6MVknNH0OiA9NsF5jf49XdBLs3TxgJ4iBJPap670S5z1ao9sDbAM-Opx3yXXpydXzVl2fvHhY7M4z_oiVzLLFQgs80pBL0omhi49rEAFONRiYFjneSW1lB2DHKEuOdQCtNBYg1KV4KLYJW83dXvvQvA4tJM3I_hVy1m7dtqunbZ_nCb4zQae5m5E_YT-lZiA_Q3wAzs3hH6tA5-wNJssGJeiXvvnia7_n25MhGicbdxsY0rlj6npy1b_mLldfFocb6Z_AF3gpPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Iheanacho, Theddeus ; Payne, Kevin ; Tsai, Jack</creator><creatorcontrib>Iheanacho, Theddeus ; Payne, Kevin ; Tsai, Jack</creatorcontrib><description>Background and Objectives Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population. This study describes a pilot Mobile Community‐based Access Team (M‐CAT) that used mobile technology and FaceTime in addition to existing community‐based case management programs to provide BUP treatment for veterans with OUD experiencing homelessness who had difficulties engaging in the regular BUP clinic. Methods We conducted a retrospective chart review of veterans enrolled in M‐CAT or the usual BUP clinic between January 2015 and December 2017 (N = 36). We ed demographic, medical, substance use, prescription, health care utilization, and drug use data from medical records. Results Twelve veterans were enrolled in M‐CAT and 24 were enrolled in BUP clinic. Mean retention in treatment was 19.2 months (standard deviation [SD] = 10.2) in M‐CAT and 36 months (SD = 27.6) in BUP clinic. At the endpoint, 66.7% (n = 8) in M‐CAT and 100% (n = 24) in BUP clinic remained on BUP. Discussion and Conclusion M‐CAT is an innovative and tailored pilot project that successfully integrated specific OUD medication treatment into existing case management programs for veterans experiencing homelessness using mobile technology and Facetime. M‐CAT can potentially increase utilization of BUP for OUD among high‐risk population of veterans experiencing homelessness who are otherwise not engaged in treatment. Scientific Significance Integrating telemedicine, BUP treatment, and community‐based case management to treat OUD among veterans experiencing homelessness is feasible with high treatment retention. (Am J Addict 2020;29:485–491)</description><identifier>ISSN: 1055-0496</identifier><identifier>EISSN: 1521-0391</identifier><identifier>DOI: 10.1111/ajad.13055</identifier><identifier>PMID: 32367557</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject><![CDATA[Adult ; Aged ; Analgesics, Opioid - therapeutic use ; Buprenorphine - therapeutic use ; Case Management - organization & administration ; Community Health Services - methods ; Community Health Services - organization & administration ; Connecticut ; Feasibility Studies ; Female ; Follow-Up Studies ; Homeless Persons ; Humans ; Life Sciences & Biomedicine ; Male ; Middle Aged ; Mobile Applications ; Opiate Substitution Treatment - methods ; Opioid-Related Disorders - drug therapy ; Patient Compliance - statistics & numerical data ; Pilot Projects ; Retrospective Studies ; Science & Technology ; Substance Abuse ; Telemedicine - methods ; Telemedicine - organization & administration ; Treatment Outcome ; Veterans Health]]></subject><ispartof>The American journal on addictions, 2020-11, Vol.29 (6), p.485-491</ispartof><rights>2020 American Academy of Addiction Psychiatry</rights><rights>2020 American Academy of Addiction Psychiatry.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>24</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000530154800001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3295-29a4e6279ac4604fb0003e9aef84f0e82275d55b0a2ea861a84ad4de8a9974143</citedby><cites>FETCH-LOGICAL-c3295-29a4e6279ac4604fb0003e9aef84f0e82275d55b0a2ea861a84ad4de8a9974143</cites><orcidid>0000-0002-7538-3611 ; 0000-0002-0329-648X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajad.13055$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajad.13055$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32367557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iheanacho, Theddeus</creatorcontrib><creatorcontrib>Payne, Kevin</creatorcontrib><creatorcontrib>Tsai, Jack</creatorcontrib><title>Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study</title><title>The American journal on addictions</title><addtitle>AM J ADDICTION</addtitle><addtitle>Am J Addict</addtitle><description>Background and Objectives Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population. This study describes a pilot Mobile Community‐based Access Team (M‐CAT) that used mobile technology and FaceTime in addition to existing community‐based case management programs to provide BUP treatment for veterans with OUD experiencing homelessness who had difficulties engaging in the regular BUP clinic. Methods We conducted a retrospective chart review of veterans enrolled in M‐CAT or the usual BUP clinic between January 2015 and December 2017 (N = 36). We ed demographic, medical, substance use, prescription, health care utilization, and drug use data from medical records. Results Twelve veterans were enrolled in M‐CAT and 24 were enrolled in BUP clinic. Mean retention in treatment was 19.2 months (standard deviation [SD] = 10.2) in M‐CAT and 36 months (SD = 27.6) in BUP clinic. At the endpoint, 66.7% (n = 8) in M‐CAT and 100% (n = 24) in BUP clinic remained on BUP. Discussion and Conclusion M‐CAT is an innovative and tailored pilot project that successfully integrated specific OUD medication treatment into existing case management programs for veterans experiencing homelessness using mobile technology and Facetime. M‐CAT can potentially increase utilization of BUP for OUD among high‐risk population of veterans experiencing homelessness who are otherwise not engaged in treatment. Scientific Significance Integrating telemedicine, BUP treatment, and community‐based case management to treat OUD among veterans experiencing homelessness is feasible with high treatment retention. (Am J Addict 2020;29:485–491)</description><subject>Adult</subject><subject>Aged</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Buprenorphine - therapeutic use</subject><subject>Case Management - organization &amp; administration</subject><subject>Community Health Services - methods</subject><subject>Community Health Services - organization &amp; administration</subject><subject>Connecticut</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Homeless Persons</subject><subject>Humans</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mobile Applications</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Patient Compliance - statistics &amp; numerical data</subject><subject>Pilot Projects</subject><subject>Retrospective Studies</subject><subject>Science &amp; Technology</subject><subject>Substance Abuse</subject><subject>Telemedicine - methods</subject><subject>Telemedicine - organization &amp; administration</subject><subject>Treatment Outcome</subject><subject>Veterans Health</subject><issn>1055-0496</issn><issn>1521-0391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ARHDP</sourceid><sourceid>EIF</sourceid><recordid>eNqNkd9O1TAYwBsjEQRvfADTa2HYbu22encYIBoMJIJeLt_Wb1Jy1i5tFzl3vICJz-iT0ONBLo1f0rRpft-f_krIa84OeYp3cAv6kBdMymdkh8ucZ6xQ_Hk6p6uMCVVuk5ch3LIUtSpfkO0iL8pKymqH_PzsOrPEA9q4cZytiavf97-OIKCmR_Pk0To_3RiL9MojxBFtpIPz9CtG9GADPbmb0Bu0vbHf6ZkbcYkh2LToNxNv6MVknNH0OiA9NsF5jf49XdBLs3TxgJ4iBJPap670S5z1ao9sDbAM-Opx3yXXpydXzVl2fvHhY7M4z_oiVzLLFQgs80pBL0omhi49rEAFONRiYFjneSW1lB2DHKEuOdQCtNBYg1KV4KLYJW83dXvvQvA4tJM3I_hVy1m7dtqunbZ_nCb4zQae5m5E_YT-lZiA_Q3wAzs3hH6tA5-wNJssGJeiXvvnia7_n25MhGicbdxsY0rlj6npy1b_mLldfFocb6Z_AF3gpPA</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Iheanacho, Theddeus</creator><creator>Payne, Kevin</creator><creator>Tsai, Jack</creator><general>Wiley</general><scope>17B</scope><scope>ARHDP</scope><scope>BLEPL</scope><scope>DVR</scope><scope>EGQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7538-3611</orcidid><orcidid>https://orcid.org/0000-0002-0329-648X</orcidid></search><sort><creationdate>202011</creationdate><title>Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study</title><author>Iheanacho, Theddeus ; Payne, Kevin ; Tsai, Jack</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3295-29a4e6279ac4604fb0003e9aef84f0e82275d55b0a2ea861a84ad4de8a9974143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Buprenorphine - therapeutic use</topic><topic>Case Management - organization &amp; administration</topic><topic>Community Health Services - methods</topic><topic>Community Health Services - organization &amp; administration</topic><topic>Connecticut</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Homeless Persons</topic><topic>Humans</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mobile Applications</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Patient Compliance - statistics &amp; numerical data</topic><topic>Pilot Projects</topic><topic>Retrospective Studies</topic><topic>Science &amp; Technology</topic><topic>Substance Abuse</topic><topic>Telemedicine - methods</topic><topic>Telemedicine - organization &amp; administration</topic><topic>Treatment Outcome</topic><topic>Veterans Health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iheanacho, Theddeus</creatorcontrib><creatorcontrib>Payne, Kevin</creatorcontrib><creatorcontrib>Tsai, Jack</creatorcontrib><collection>Web of Knowledge</collection><collection>Web of Science - Social Sciences Citation Index – 2020</collection><collection>Web of Science Core Collection</collection><collection>Social Sciences Citation Index</collection><collection>Web of Science Primary (SCIE, SSCI &amp; AHCI)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The American journal on addictions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iheanacho, Theddeus</au><au>Payne, Kevin</au><au>Tsai, Jack</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study</atitle><jtitle>The American journal on addictions</jtitle><stitle>AM J ADDICTION</stitle><addtitle>Am J Addict</addtitle><date>2020-11</date><risdate>2020</risdate><volume>29</volume><issue>6</issue><spage>485</spage><epage>491</epage><pages>485-491</pages><issn>1055-0496</issn><eissn>1521-0391</eissn><abstract>Background and Objectives Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population. This study describes a pilot Mobile Community‐based Access Team (M‐CAT) that used mobile technology and FaceTime in addition to existing community‐based case management programs to provide BUP treatment for veterans with OUD experiencing homelessness who had difficulties engaging in the regular BUP clinic. Methods We conducted a retrospective chart review of veterans enrolled in M‐CAT or the usual BUP clinic between January 2015 and December 2017 (N = 36). We ed demographic, medical, substance use, prescription, health care utilization, and drug use data from medical records. Results Twelve veterans were enrolled in M‐CAT and 24 were enrolled in BUP clinic. Mean retention in treatment was 19.2 months (standard deviation [SD] = 10.2) in M‐CAT and 36 months (SD = 27.6) in BUP clinic. At the endpoint, 66.7% (n = 8) in M‐CAT and 100% (n = 24) in BUP clinic remained on BUP. Discussion and Conclusion M‐CAT is an innovative and tailored pilot project that successfully integrated specific OUD medication treatment into existing case management programs for veterans experiencing homelessness using mobile technology and Facetime. M‐CAT can potentially increase utilization of BUP for OUD among high‐risk population of veterans experiencing homelessness who are otherwise not engaged in treatment. Scientific Significance Integrating telemedicine, BUP treatment, and community‐based case management to treat OUD among veterans experiencing homelessness is feasible with high treatment retention. (Am J Addict 2020;29:485–491)</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>32367557</pmid><doi>10.1111/ajad.13055</doi><orcidid>https://orcid.org/0000-0002-7538-3611</orcidid><orcidid>https://orcid.org/0000-0002-0329-648X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1055-0496
ispartof The American journal on addictions, 2020-11, Vol.29 (6), p.485-491
issn 1055-0496
1521-0391
language eng
recordid cdi_pubmed_primary_32367557
source MEDLINE; Access via Wiley Online Library
subjects Adult
Aged
Analgesics, Opioid - therapeutic use
Buprenorphine - therapeutic use
Case Management - organization & administration
Community Health Services - methods
Community Health Services - organization & administration
Connecticut
Feasibility Studies
Female
Follow-Up Studies
Homeless Persons
Humans
Life Sciences & Biomedicine
Male
Middle Aged
Mobile Applications
Opiate Substitution Treatment - methods
Opioid-Related Disorders - drug therapy
Patient Compliance - statistics & numerical data
Pilot Projects
Retrospective Studies
Science & Technology
Substance Abuse
Telemedicine - methods
Telemedicine - organization & administration
Treatment Outcome
Veterans Health
title Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T13%3A00%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mobile,%20Community%E2%80%90Based%20Buprenorphine%20Treatment%20for%20Veterans%20Experiencing%20Homelessness%20With%20Opioid%20Use%20Disorder:%20A%20Pilot,%20Feasibility%20Study&rft.jtitle=The%20American%20journal%20on%20addictions&rft.au=Iheanacho,%20Theddeus&rft.date=2020-11&rft.volume=29&rft.issue=6&rft.spage=485&rft.epage=491&rft.pages=485-491&rft.issn=1055-0496&rft.eissn=1521-0391&rft_id=info:doi/10.1111/ajad.13055&rft_dat=%3Cwiley_pubme%3EAJAD13055%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32367557&rfr_iscdi=true